Advertisement

Topics

NovaBiotics Ltd Company Profile

09:24 EST 14th December 2018 | BioPortfolio

NovaBiotics Ltd is a clinical-stage speciality biotechnology company focused on the application of first-in-class anti-infective technology for difficult-to-treat, medically unmet fungal and bacterial conditions.

As a leading innovator in the anti-infectives space, Novabiotics' business model is to develop candidate therapeutics to early/mid clinical proof of concept prior to further development of our product candidates and technology platform with commercialisation, out-licensing or co-development partners thereafter.

Using informed, rational drug design principles versus high-risk screening strategies, the company has streamlined this process such that we have delivered products to clinic in less than 5 years from patent priority dates.

Founded in Aberdeen by Dr. Deborah O'Neil in 2004, NovaBiotics Board of Directors provides a wealth of expertise in the biotechnology and pharmaceutical sector and the science team now in place (comprising immunology, microbiology and antimicrobial peptide expertise) provides a wealth of technological know-how and skills including proven, sector-specific expertise in anti-infective business development.

Over-use of antibiotics and antifungals and consequent drug resistance leaves the application and success of current antimicrobial therapies ever more limited. Global healthcare is facing an unprecedented crisis with the current and predicted future unmet clinical need for effective, safe and resistance-free therapies to combat bacterial, fungal, viral and other infectious diseases and conditions. Chemistry-led approaches have failed to solve this problem and so NovaBiotics has employed a very different approach, informed or rational drug design, with nature as the template for a totally novel class of antimicrobial therapies that have the potential to meet the need for safer, more effective antifungal and antibacterial treatments.

NovaBiotics' proprietary technology comprises peptides; biologic molecules that in nature form the cornerstone of the body's first line of defence against the spectrum of potentially harmful microbes (bacteria, fungi, viruses, protozoa) with which we come into contact daily. NovaBiotics has capitalised on the benefical properties of these natural infection-fighting agents and has engineered third-generation derivatives that can be applied for the treatment and even prevention of a range of fungal and bacterial infections.

Importantly, the mode of action of NovaBiotics' compounds is such that they kill rather than merely inhibit pathogens and the likelihood of acquired or transmitted pathogen resistance developing in micro-organisms which have been exposed to the peptides is highly unlikely, if not impossible.

Location

Cruickshank Building
Craibstone
Aberdeen
AB21 9TR
United Kingdom

Contact

Phone: +44 (0)1224 711377
Fax: +44 (0)1224 711370
Email: info@novabiotics.co.uk


News Articles [7 Associated News Articles listed on BioPortfolio]

Taro Terminates Agreement with NovaBiotics

License agreement for anti-fungal peptide treatment, Novexatin® Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) announced today that it has ...

NovaBiotics' oral Lynovex improves outcomes in Phase II for CF

Cystic Fibrosis: NovaBiotics Advances Old Dog With New Tricks

Lynovex, a reformulated version of a molecule which has been around for decades for a rare metabolic disease, has just...    

Beyond Rebates: PhRMA Wants HHS To ‘De-Link’ Supply Chain Compensation From List Price

Focus should not be limited to rebates in Medicare Part D, manufacturers advise in comments on HHS drug pricing blueprint...   

Finance Watch: 2018 Biopharma VC Investment Could Beat 2017 One Quarter Ahead Of Schedule

With biopharma venture capital investment of $9.67bn during the first half, 2018's total is on track to beat 2017 in...   

Novabiotics Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 11072018] Prices from USD $250

SummaryNovabiotics Ltd Novabiotics is a biotechnology company that designs and develops antiinfectives for treating diseases with unmet medical needs. The company's pipeline products include Novexatin...

Novabiotics Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23042018] Prices from USD $250

SummaryNovabiotics Ltd Novabiotics is a biotechnology company that designs and develops antiinfectives for treating diseases with unmet medical needs. The company's pipeline products include Novexatin...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

NovaBiotics Ltd

NovaBiotics Ltd is a clinical-stage speciality biotechnology company focused on the application of first-in-class anti-infective technology for difficult-to-treat, medically unmet fungal and bacteri...

More Information about "NovaBiotics Ltd" on BioPortfolio

We have published hundreds of NovaBiotics Ltd news stories on BioPortfolio along with dozens of NovaBiotics Ltd Clinical Trials and PubMed Articles about NovaBiotics Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NovaBiotics Ltd Companies in our database. You can also find out about relevant NovaBiotics Ltd Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record